CLOV 📈 Clover Health Investments - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US18914F1030
CLOV: Medicare Advantage Plans, Cloud-Based Software, Chronic Disease Management
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee. Web URL: https://www.cloverhealth.com/en/
Additional Sources for CLOV Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CLOV Stock Overview
| Market Cap in USD | 1,714m |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| GiC Sub-Industry | Health Care Services |
| IPO / Inception | 2001-01-02 |
CLOV Stock Ratings
| Growth 5y | -55.2% |
| Fundamental | -35.9% |
| Dividend | - |
| Rel. Strength Industry | 4362 |
| Analysts | 3.67/5 |
| Fair Price Momentum | 2.75 USD |
| Fair Price DCF | - |
CLOV Dividends
No Dividends PaidCLOV Growth Ratios
| Growth Correlation 3m | -28.9% |
| Growth Correlation 12m | 85% |
| Growth Correlation 5y | -76.1% |
| CAGR 5y | -22.37% |
| CAGR/Mean DD 5y | -0.30 |
| Sharpe Ratio 12m | 1.75 |
| Alpha | 186.92 |
| Beta | 1.47 |
| Volatility | 74.99% |
| Current Volume | 5142k |
| Average Volume 20d | 4471.1k |
What is the price of CLOV stocks?
As of December 22, 2024, the stock is trading at USD 3.23 with a total of 5,142,043 shares traded.
Over the past week, the price has changed by +3.86%, over one month by -3.58%, over three months by +11.00% and over the past year by +229.59%.
As of December 22, 2024, the stock is trading at USD 3.23 with a total of 5,142,043 shares traded.
Over the past week, the price has changed by +3.86%, over one month by -3.58%, over three months by +11.00% and over the past year by +229.59%.
Is Clover Health Investments a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Clover Health Investments (NASDAQ:CLOV) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -35.85 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLOV as of December 2024 is 2.75. This means that CLOV is currently overvalued and has a potential downside of -14.86%.
Probably not. Based on ValueRay Fundamental Analyses, Clover Health Investments (NASDAQ:CLOV) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -35.85 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLOV as of December 2024 is 2.75. This means that CLOV is currently overvalued and has a potential downside of -14.86%.
Is CLOV a buy, sell or hold?
Clover Health Investments has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold CLOV.
Clover Health Investments has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold CLOV.
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecast for CLOV stock price target?
According to ValueRays Forecast Model, CLOV Clover Health Investments will be worth about 3.1 in December 2025. The stock is currently trading at 3.23. This means that the stock has a potential downside of -3.72%.
According to ValueRays Forecast Model, CLOV Clover Health Investments will be worth about 3.1 in December 2025. The stock is currently trading at 3.23. This means that the stock has a potential downside of -3.72%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 4.2 | 31% |
| Analysts Target Price | 1.9 | -39.9% |
| ValueRay Target Price | 3.1 | -3.7% |